drugset / Trial / NCT06105671
U-LABA/ICS Effects on Exercise Performance, Formoterol
RandomizedCrossoverQuadruple-blindBasic science
Summary
The purpose of the project is to investigate exercise performance in well-trained individuals in a crossover design following varying degrees of bronchodilation/constriction intervention using current standard procedures.
Timeline
- Start
- 2024-01-05
- Primary completion
- 2024-07-04
- Completion
- 2024-07-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 1920 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 54 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 120 ug | Inhaled |
| Subject | Mannitol | Diagnostic / imaging agent | 600 mg | Inhaled |
Indications
No indication recorded.